Jefferies analyst John Campbell upgraded ALS Ltd. to Buy from Hold with a price target of A$17.40, up from A$13.20. Life sciences volumes are benefiting from megatrends and commodities are poised for a volume liftoff, the analyst tells investors.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CPBLF: